Q2 FY2026 EarningsQ2 FY2026 results missed consensus across both top and bottom lines. Revenue of $8.06M was 3.5% above the $7.78M consensus, but significant expense scaling led to a GAAP EPS of $(0.04) vs. the $(0.03) expected. Gross margin of 48.69% fell short of the 52.45% mean estimate. Despite the quarterly miss, the company reaffirmed its FY2026 revenue guidance of $45M-$50M, supported by a $66.3M revenue pipeline and the upcoming launch of the HitRix platform.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Health In Tech(HIT) the Revenue is 8.057 M (-13.5%), Beat estimate;the EBIT is -3.438 M (-574.2%), Miss estimate;the EPS is -0.04 (-500%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.01B13.50%
0.01B16.46%
+0.00B2.96%
EBITMiss expectations
-0.00B574.20%
-0.00B419.68%
-0.00B154.52%
EPSMiss expectations
-0.04500.00%
-0.03400.00%
-0.0100100.00%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf